| Literature DB >> 29331352 |
Amanda Cibelly Brito Gois1, Leandro de Araújo Pernambuco2, Kenio Costa de Lima3.
Abstract
INTRODUCTION: During the aging process, natural modifications occur in the larynx and the structures involved in phonation which explain the specific characteristics found in the voices of elderly persons. When, at any moment, a voice fails and there is interference with communication, a voice disorder has occurred. This can generate disadvantages in communicative efficiency and have a negative impact on quality of life, compromising mechanisms of socialization, the maintenance of autonomy, and the sense of well-being. Nevertheless, there appears to be little clarity about which factors are associated with voice disorders in this population, especially from an epidemiological perspective.Entities:
Keywords: Aged; Cross-sectional studies; Distúrbios de voz; Epidemiologia; Epidemiology; Estudos transversais; Idoso; Voice disorders
Mesh:
Year: 2017 PMID: 29331352 PMCID: PMC9449164 DOI: 10.1016/j.bjorl.2017.11.002
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Characteristics of studies included, with methodological quality evaluated in accordance with the STROBE criteria for cross-sectional studies.
| Reference | Location | Population | Sample | Gender | Age | Instrument | Factors associated with vocal alterations |
|---|---|---|---|---|---|---|---|
| Roy et al. (2007) | Utah and Kentucky, USA | Elderly individuals aged 65 years or older | 117 elderly individuals | 39 (33.3%) men and 78 (66.7%) women | 65–94 years (76.1 ± 8.5) | Interview based on adaptation of instrument used in previous study (Roy, Merril, Thibeault, Parsa, Gray & Smith, 2004) | Colds |
| Sore throat | |||||||
| Gastroesophageal reflux | |||||||
| Arthritis | |||||||
| Thyroid problems | |||||||
| Bronchitis | |||||||
| Sleep disorders | |||||||
| Feeling anxious/frustrated | |||||||
| Ryu et al. (2015) | Korea | Elderly individuals aged 65 years or older | 3759 elderly individuals | 1542 (41%) men and 2217 (59%) women | 65 years and older (72.4 ± 5.5) | The Korea National Health and Nutrition Examination Survey (KNHANES) | Area of residence |
| Body Mass Index (BMI) | |||||||
| Self-rated health status | |||||||
| Asthma | |||||||
| Chronic obstructive pulmonary disease (COPD) | |||||||
| Thyroid disease | |||||||
| Cerebrovascular disease | |||||||
| Vocal fold disease | |||||||
| Depression | |||||||
Figure 1Flowchart for selection of articles.
Essential items that should be described in observational studies, according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) declaration.
| Items | Roy et al. (2007 | Ryu et al. (2015) |
|---|---|---|
| 1.1 Indicate the study's design with a commonly used term in the title or the abstract | + | + |
| 1.2 Provide in the abstract an informative and balanced summary of what was done and what was found | + | + |
| 2. Explain the scientific background and rationale for the investigation being reported | + | + |
| 3. State specific objectives, including any prespecified hypotheses. | + | + |
| 4. Present key elements of study design early in the paper. | − | + |
| 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection. | + | + |
| 6.1 Give the eligibility criteria, and the sources and methods of selection of participants. | + | + |
| 7. Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. | ? | ? |
| 8. For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group. | ? | + |
| 9. Describe any efforts to address potential sources of bias | − | − |
| 10. Explain how the study size was arrived at | ? | − |
| 11. Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why. | ? | ? |
| 12.1 Describe all statistical methods, including those used to control for confounding. | + | + |
| 12.2 Describe any methods used to examine subgroups and interactions | + | − |
| 12.3 Explain how missing data were addressed(“missing data”) | − | − |
| 12.4 If applicable, describe analytical methods taking account of sampling strategy. | − | + |
| 12.5 Describe any sensitivity analyses. | − | − |
| 13.1 Report numbers of individuals at each stage of study; e.g. numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed | ? | − |
| 13.2 Give reasons for non-participation at each stage. | − | − |
| 13.3 Consider use of a flow diagram | − | − |
| 14.1 Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures and potential confounders. | + | + |
| 14.2 Indicate number of participants with missing data for each variable of interest. | − | − |
| 15. Report numbers of outcome events or summary measures. | + | + |
| 16.1 Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g. 95% Confidence Interval). Make clear which confounders were adjusted for and why they were included. | − | − |
| 16.2 Report category boundaries when continuous variables were categorized. | + | + |
| 16.3 If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period. | − | − |
| 17. Report other analyses done (e.g. analyses of subgroups and interactions), and sensitivity analyses. | + | − |
| 18. Summarize key results with reference to study objectives. | + | + |
| 19. Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias. | − | + |
| 20. Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence. | + | + |
| 21. Discuss the generalizability (external validity) of the study results. | + | + |
| 22. Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based. | − | + |